Michelle Ann B. Eala

Michelle Ann B. Eala

Auto-generated profile, based on publicly available information

Michelle Ann B. Eala

College of Medicine, University of the Philippines, Manila, Philippines

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2023 in The Lancet Regional Health - Western Pacific
Verified
Journal Article
Open access
EFErin Jay G. Feliciano
Erin Jay G. Feliciano
FHFrances Dominique V. Ho
Frances Dominique V. Ho
KYKaisin Yee
Kaisin Yee
JPJoseph A. Paguio
Joseph A. Paguio
MEMichelle Ann B. Eala
Michelle Ann B. Eala
EDEdward Christopher Dee
Edward Christopher Dee

4 July 2023 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Closed access
PDF file
EDEdward Christopher Dee
Edward Christopher Dee
MEMichelle Ann B Eala
Michelle Ann B Eala
JRJanine Patricia G Robredo
Janine Patricia G Robredo
DRDuvern Ramiah
Duvern Ramiah
AHAnne Hubbard
Anne Hubbard
SGSurbhi Grover
Surbhi Grover
Health and politics are deeply intertwined. In the context of national and global cancer care delivery, political forces—the political determinants of health—influence every level of the cancer care continuum. We explore the “3-I” framework, which structures the upstream political forces that affect policy choices in the context of actors' interests, ideas, and institutions, to examine how political determinants of health underlie cancer disparities. Borrowing from the work of PA Hall, M-P Pomey, CJ Ho, and other thinkers, interests are the agendas of individuals and groups in power. Ideas represent beliefs or knowledge about what is or what should be. Institutions define the rules of play. We provide examples from around the world: Political interests have helped fuel the establishment of cancer centers in India and have galvanized the 2022 Cancer Moonshot in the United States. The politics of ideas underlie global disparities in cancer clinical trials—that is, in the distribution of epistemic power. Finally, historical institutions have helped perpetuate disparities related to racist and colonialist legacies. Present institutions have also been used to improve access for those in greatest need, as exemplified by the Butaro Cancer Center of Excellence in Rwanda. In providing these global examples, we demonstrate how interests, ideas, and institutions influence access to cancer care across the breadth of the cancer continuum. We argue that these forces can be leveraged to promote cancer care equity nationally and globally.

28 July 2022 in Preventive Medicine Reports
Verified
Journal Article
Open access
FHFrances Dominique V. Ho
Frances Dominique V. Ho
MAMa Veronica Pia N. Arevalo
Ma Veronica Pia N. Arevalo
PCPatricia Therese S. de Claro
Patricia Therese S. de Claro
LJLuisa E. Jacomina
Luisa E. Jacomina
MGMaria Julieta V. Germar
Maria Julieta V. Germar
MEMichelle Ann B. Eala
Michelle Ann B. Eala
• Most Filipino breast and cervical cancer patients are diagnosed with late-stage disease. • Poor access to breast and cervical screening contributes to delayed diagnosis. • Access barriers include geographic disparities and high out-of-pocket costs of care. • Sociocultural factors also contribute to low screening uptake for women’s cancers. • Multisectoral interventions are needed to expand cancer screening in the Philippines.

12 October 2022 in The Lancet Regional Health - Western Pacific
Verified
Journal Article
Open access
EDEdward Christopher Dee
Edward Christopher Dee
CAChristian Daniel U Ang
Christian Daniel U Ang
FTFrederic Ivan L Ting
Frederic Ivan L Ting
ETEnrico D Tangco
Enrico D Tangco
MEMichelle Ann B. Eala
Michelle Ann B. Eala

17 June 2022 in Cancer
Verified
Journal Article
Closed access
MEMichelle Ann B. Eala
Michelle Ann B. Eala
EDEdward Christopher Dee
Edward Christopher Dee
OGOphira Michal Ginsburg
Ophira Michal Ginsburg
MCMelvin LK Chua
Melvin LK Chua
NBNirmala Bhoo-Pathy
Nirmala Bhoo-Pathy

4 November 2022 in JCO Global Oncology
Verified
Journal Article
Open access
MEMichelle Ann B. Eala
Michelle Ann B. Eala
EMEthan Angelo S. Maslog
Ethan Angelo S. Maslog
EDEdward Christopher Dee
Edward Christopher Dee
FTFrederic Ivan Ting
Frederic Ivan Ting
JTJean Anne B. Toral
Jean Anne B. Toral
JCJohanna Patricia A. Cañal
Johanna Patricia A. Cañal
PURPOSE: In the Philippines, a lower middle-income country in Southeast Asia, 6 of 10 Filipinos die without seeing a doctor. To ensure universal access to cancer care, providers must be equitably distributed. Therefore, we evaluated the distribution of oncologists across all 17 regions in the Philippines. METHODS: We gathered data from the official websites of national medical societies on their members' regional area of practice: Philippine Society of Medical Oncology, Philippine Radiation Oncology Society, Surgical Oncology Society of the Philippines, Society of Gynecologic Oncologists of the Philippines, and Philippine Society of Hospice and Palliative Medicine. We compared this with the regional census to determine the number of board-certified oncologists per 100,000 Filipinos. RESULTS: For a population of almost 110 million, the Philippines has a total of 348 medical oncologists, 164 surgical oncologists, 99 radiation oncologists, 142 gynecologic oncologists, and 35 hospice and palliative medicine (HPM) specialists. This translates to 0.32 medical oncologists, 0.15 surgical oncologists, 0.09 radiation oncologists, 0.13 gynecologic oncologists, and 0.03 HPM specialists for every 100,000 Filipinos. The number of oncologists is highest in the National Capital Region in Luzon and lowest in the Bangsamoro Autonomous Region in Muslim Mindanao. All regions have at least one medical and gynecologic oncologist. Two regions (12%) have no surgical oncologists, five regions (29%) have no radiation oncologists, and eight regions (47%) have no HPM specialists. CONCLUSION: Efforts are needed to increase the number of oncologists and improve equity in their distribution to ensure universal access to cancer care in the Philippines.